Skip to content

INUSpheresis

A German double-filtration blood wash, sold as removing what modern life deposits in you. The filter is real; the claims run past what has been measured.

Blood-based therapiesprocedureEarly stage

Availability Offered in select countries

What it is

INUSpheresis is a branded form of double-filtration plasmapheresis developed in Germany by Richard Straube. A machine separates plasma from blood cells, pushes the plasma through a second filter with a defined pore size, and returns it. Clinics show patients the residue caught in the filter.

Why people choose this treatment

The promise is subtraction. Marketing names microplastics, heavy metals, spike protein, oxidized lipids, and inflammatory mediators as what gets removed. People who book it are usually living with long COVID, chronic fatigue, suspected toxin exposure, or autoimmune symptoms nobody has resolved.

How it's delivered

Two sessions of two to three hours each, generally across a week, at a clinic in Germany, Switzerland, Austria, or Cyprus, with access in both arms, anticoagulation, and labs before and after. These clinics work under European regulation, not FDA; there is no United States equivalent.

Where the evidence stands

Double-filtration plasmapheresis is established medicine for defined targets, chiefly lipid apheresis in familial hypercholesterolemia, where the molecule removed is known and measurable. INUSpheresis for aging, fatigue, or toxic load is a different claim, resting on case series and clinic-collected observation rather than randomized trials. What the filter catches has not been characterized in peer-reviewed work, and no controlled study connects a session to a durable outcome. A dirty filter is not evidence.

Estimated cost

  • EUR 2,690 per session, published Cyprus rate
  • EUR 5,400–18,000 per course, Germany and Switzerland
  • Add-on infusions priced separately
  • Travel on top; not covered by insurance

Who offers it

Observed at Ayus Medical Group in Basel, Biologicum Hamburg, ELLANN Health in Berlin, and the Apheresis Center in Larnaca. No United States provider; outside FDA oversight.

How we know

Observed in provider menus on our last research pass; each listing is stamped when verified. We may be compensated when you contact providers through Longevity.io; payment never affects ranking.

Go deeper

The full guide to therapeutic plasma exchange covers the better-studied cousin of this procedure, including the Buck Institute trial.

Longevity.io is for educational purposes only and is not medical advice. If a clinic cannot name the molecule it intends to remove and how it will measure the removal, that is the question to press before you fly. Confirm eligibility, services, and pricing directly with any provider.

Your Longevity Blueprint

Build your starting plan.

A few short questions, about two minutes. The Blueprint recommends where to start and explains why.

Build my Blueprint